The Pharma Letter | Final Data from the Phase 2 COSMOS Study of Janssen's Once-Daily Simeprevir ... MarketWatch In Europe it is a leading cause of liver transplantation.7. The World Health Organisation (WHO) and the European Association for the Study of the Liver (EASL) estimate that 150 million people worldwide were chronically infected with HCV in 2011.8 The ... New data reveals positive outcomes for hepatitis C transplant patients Sovaldi Continues to Excel in Trials with Hep C, Advanced Liver Disease |
